Pro PG receives S19A approval for Amoxicillin Powder for Oral Suspension 250mg/5ml (West-Ward)

Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position.

For current Australian shortage and supply information, see medicine shortages in Australia.

Dear Healthcare Professional,

Shortage of AMOXYCILLIN SANDOZ amoxicillin trihydrate 250mg/5mL powder for oral suspension bottle ARTG: 93720

Pro Pharmaceuticals Group (ProPG) advises that due to a shortage of Australian registered AMOXYCILLIN SANDOZ amoxicillin trihydrate 250mg/5mL powder for oral suspension bottle ARTG: 93720 sponsored by Sandoz Pty Ltd is currently in shortage due to manufacturing issues.

Pro Pharmaceuticals Group has arranged for the supply of an alternative product, Amoxicillin Powder for Oral Suspension 250mg/5ml (West-Ward). The S19A product is registered and marketed in the USA and the supply is authorized under an exemption granted by the TGA under Section 19A of the Therapeutic Goods Act, 1989 until 28th February 2023.